Analyst Insights: DigitalGlobe, Navistar, Boston Scientific, BioMarin, Qlik Technologies June 12th

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

DigitalGlobe, Inc. (NYSE:DGI): Dougherty confirms DigitalGlobe providing imagery to Apple.

Navistar International Corp. (NYSE:NAV): Navistar weakness a buying opportunity, says UBS.

Boston Scientific Corporation (NYSE:BSX): Wells Fargo said Boston Scientifc (NYSE:BSX) should be a beneficiary St. Jude’s (NYSE:STJ) Durata lead issue.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Piper Jaffray said BioMarin is a takeout candidate but a deal is unlikely prior to the release of its key clinical data in 2H 2012. Shares are Outperform rated with a $43 price target.

Qlik Technologies, Inc. (NASDAQ:QLIK): After Qlik agreed to buy Expressor Software, an ETL and data management solution provider, JPMorgan believes the integration risk is minimum, since the companies were already partners. The firm thinks that the acquisition will reduce QlikView deployment times versus traditional tools and it maintains an Overweight rating on Qlik.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business